Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Interim Management Statement

18 May 2023 10:23

RNS Number : 8917Z
Mandarin Oriental International Ltd
18 May 2023
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

18th May 2023 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2023.

 

The Group recorded an underlying profit in the first quarter of 2023, driven by improved performance from both the Group's owned hotels and its management business. RevPAR grew substantially in Asia compared to last year, as the region benefitted from the removal of travel restrictions. As a result, the Group's owned hotels saw a significantly improved performance, particularly in Hong Kong, Tokyo, and Bangkok. In the rest of the world, our hotels were also able to achieve a higher RevPAR compared to both last year and 2019, driven by strong rates.

 

The first quarter saw progress on a number of hotel developments. In January, the Group announced a new management contract for a luxury beach resort in Mallorca, Spain, scheduled to open by the end of 2024. In February, after three years' work, the Emirates Palace hotel in Abu Dhabi was rebranded as Emirates Palace Mandarin Oriental, Abu Dhabi. In March, Mandarin Oriental, Singapore, closed for a substantial renovation; it is expected to reopen in September 2023.

 

As a result of improved trading conditions, the Group generated underlying earnings before interest, tax, depreciation, and amortisation ('EBITDA') of US$30 million, a substantial increase from the EBITDA loss of US$1 million in the first quarter of 2022. Owned hotels reported an EBITDA of US$19 million, with almost all hotels delivering increased financial performance. The management business saw significant growth and generated higher fees, with hotels, particularly in Hong Kong and Mainland China, contributing to an EBITDA of US$7 million. Unaudited underlying profit in the first quarter was US$3 million, much improved from an underlying loss of US$26 million in 2022.

 

The Group's redevelopment project in Causeway Bay, Hong Kong, formerly the site of The Excelsior hotel, is ongoing, in line with our budget, and is expected to complete in early 2025.

 

Consolidated net debt as at 31st March 2023 reduced to US$311 million (US$376 million at 31st December 2022). The Group's liquidity position remains robust, with US$453 million in available committed debt facilities and US$306 million of cash reserves. Gearing was 6% of adjusted shareholders' funds.

 

On 2nd May 2023, the Company announced that Laurent Kleitman would replace James Riley as Group Chief Executive of Mandarin Oriental International Limited with effect from 1st September 2023.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the standard segment of the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley

(852) 2895 9288

Matthew Bishop

(852) 2895 9288

 

Brunswick Group Limited

William Brocklehurst

(852) 5685 9881

 

This and other Group announcements can be accessed online at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKVLBFXELLBBB
Date   Source Headline
29th Jul 202110:23 amRNS2021 HALF YEAR FINANCIAL STATEMENTS
29th Jul 202110:22 amRNS2021 Half Yearly Results
29th Jul 202110:19 amRNSPT Hero Supermarket Tbk First Half 2021 Results
30th Jun 202110:22 amRNSReport on Payments to Govts
30th Jun 202110:20 amRNSTotal Voting Rights
4th Jun 202110:42 amRNSDirector/PDMR Shareholding
2nd Jun 202110:35 amRNSDirector/PDMR Shareholding
1st Jun 20217:05 amRNSTotal Voting Rights
12th May 202110:23 amRNSDirector/PDMR Shareholding
10th May 202110:21 amRNSAdditional Listing
6th May 202112:18 pmRNSResult of AGM
6th May 202110:20 amRNSInterim Management Statement
5th May 202110:24 amRNSInterim Management Statement
5th May 202110:23 amRNSInterim Management Statement
5th May 202110:22 amRNSInterim Management Statement
4th May 20217:00 amRNSDividend
30th Apr 202111:03 amRNSPT Hero Supermarket Tbk First Quarter 2021 Results
30th Apr 202110:33 amRNSTotal Voting Rights
29th Apr 202112:58 pmRNSDirector/PDMR Shareholding
28th Apr 202111:07 amRNSDividend
27th Apr 202110:34 amRNSJC&C Interim Management Statement
21st Apr 202110:45 amRNSPT Astra 2021 First Quarter Financial Statements
16th Apr 202110:26 amRNSHolding(s) in Company
16th Apr 202110:25 amRNSHolding(s) in Company
16th Apr 202110:24 amRNSHolding(s) in Company
15th Apr 20218:26 amRNSCancellation of Listing of Jardine Strategic
15th Apr 20217:00 amRNSCompletion of Acquisition of JSH by JMH
12th Apr 20211:25 pmRNSUpdate on Simplification of JM & Acquisition of JS
8th Apr 202110:25 amRNSAnnual Financial Report
7th Apr 202110:20 amRNSCirc re. Scrip Dividend Scheme
31st Mar 202110:57 amRNSTotal Voting Rights
25th Mar 20219:36 amRNSBlock listing Interim Review
24th Mar 20219:32 amRNSDirector Declaration
18th Mar 20217:00 amRNSCir re. Publication of Shareholder Circular
11th Mar 202111:23 amRNS2020 Preliminary Announcement of Results
11th Mar 20219:16 amRNS2020 Preliminary Announcement of Results
11th Mar 20219:16 amRNS2020 Preliminary Announcement of Results
11th Mar 20219:16 amRNS2020 Preliminary Announcement of Results
10th Mar 20219:38 amRNSFull Year 2020 Results of PT Hero
8th Mar 20217:00 amRNSRecommended Cash Acquisition of Jardine Strategic
8th Mar 20217:00 amRNSSimplification of Jardine Matheson Structure
26th Feb 202110:08 amRNSJardine Cycle & Carriage – Final Results
26th Feb 20219:30 amRNSTotal Voting Rights
25th Feb 20219:54 amRNSAstra International - Final Results
9th Feb 20219:39 amRNSDirector/PDMR Shareholding
8th Feb 202111:16 amRNSTransaction in Own Shares
1st Feb 202111:33 amRNSTransaction in Own Shares
29th Jan 202110:45 amRNSTotal Voting Rights
29th Jan 202110:43 amRNSTransaction in Own Shares
28th Jan 20219:45 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.